Bank Of New York Mellon Corp Axcella Health Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.31 - $0.77 $13,507 - $33,550	43,572 New	43,572 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$0.16 - $1.1 $6,971 - $47,929	43,572 New	43,572 $14,000
Q2 2021 Aug 11, 2021	SELL	$3.08 - $5.13 $129,963 - $216,465	-42,196 Reduced 49.2%	43,572 $0
Q1 2021 May 13, 2021	SELL	$4.55 - $6.72 $6,133 - $9,058	-1,348 Reduced 1.55%	85,768 $0
Q4 2020 Feb 09, 2021	BUY	$4.24 - $5.97 $220,904 - $311,037	52,100 Added 148.79%	87,116 $0
Q3 2020 Nov 12, 2020	SELL	$4.12 - $5.91 $6,353 - $9,113	-1,542 Reduced 4.22%	35,016 $0
Q2 2020 Aug 12, 2020	BUY	$2.94 - $7.7 $36,167 - $94,725	12,302 Added 50.72%	36,558 $0
Q1 2020 May 06, 2020	BUY	$2.25 - $5.24 $9,873 - $22,993	4,388 Added 22.09%	24,256 $0
Q4 2019 Feb 14, 2020	BUY	$3.08 - $5.9 $61,193 - $117,221	19,868 New	19,868 $0

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.